Skip to main content

Hernandez Marlow's Form 4/A amendment

Amended

Cano Health, Inc. (CANO) · filed Aug 23, 2021

Accession no.
0000899243-21-033876
Filed
Aug 23, 2021
Trade date
Aug 16-17, 2021
Filing delay
7 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Aug 18, 2021

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $2.08M. It was filed 7 days after the trade.

This amendment replaces 0000899243-21-033441 (filed Aug 18, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hernandez MarlowCIK 0001865483Director, Officer (CEO and President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2021Class A Common StockPPurchaseAcquired+120,000$10.16F1+$1,219,200120,000Direct
Aug 17, 2021Class A Common StockPPurchaseAcquired+90,000$9.55F2+$859,500210,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 16, 2021Class A Common StockPPurchaseAcquired+160,000$2.77F3+$443,200160,000Direct
Aug 17, 2021Class A Common StockPPurchaseAcquired+90,000$2.51F4+$225,900250,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.05 to $10.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.34 to $9.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.70 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.

Referenced by the price of 1 transaction in Table II.

F4

The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $2.40 to $2.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(4) to this Form 4.

Referenced by the price of 1 transaction in Table II.

F5

Common limited liability company units of Primary Care (ITC) Intermediate Holdings, LLC ("PCIH Common Units"), together with an equal number of shares of the Issuer's Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), are exchangeable for either cash or shares of Class A Common Stock on a one-for-one basis. The PCIH Common Units have no expiration date.

F6

The Class B Common Stock and PCIH Common Units are owned indirectly by the reporting person through Hernandez Borrower Holdings, LLC. The reporting person has sole voting and dispositive power with respect to all of the securities held by Hernandez Borrower Holdings, LLC and therefore is the beneficial owner of these securities.

Read the full filing on SEC EDGAR (opens in a new tab)